23andMe’s conflict with the FDA did slow the stream of people subscribing to the service, but co-founder Anne Wojcicki still thinks the company is helping create a future where more time and money are spent predicting and preventing disease, as opposed to our current, treatment-based approach.
The researchers behind the acid bath stem cell method that caused a stir in January have asked to retract the paper. No other scientists have been able to reproduce the results, and many question the images and findings in the paper.
On most issues, the public debate follows a normal distribution curve, with the majority in the ‘muddled middle’. That’s not proving to be the case in the increasingly heated discussion over ’3 parent babies’.
With the FDA close to approving the AquAdvantage GM salmon, wariness by supermarkets and aggressive opposition from anti-GMO NGOs raises questions about whether it will survive in the marketplace.
The NGO Biosciences for Farming in Africa has produced a collection of essays focused on “how will we be able to produce 70% more food sustainably, sufficient to feed a predicted population of 9 billion in 2050.”
The anti-biotech group GMO Inside called on Starbucks to serve only organic milk, thereby eliminating GMOs, from its stores in 62 countries. But it looks like Starbucks won’t be changing its menu anytime soon.
HIV has proven to be a frustrating challenge to scientists looking for a magic-bullet cure. Researchers are now evaluating an experimental technique that would disable the CCR5 gene, the protein that allows the HIV to borrow into the T cells.
”Why do you grow Bt corn?” Dave Walton answers the question and delves deeper into the reasons of why a farmer would choose to grow a GM crop with the ability to produce a protein that paralyzes pests that can have a devastating effect on the harvest.